Literature DB >> 21486565

PANDER KO mice on high-fat diet are glucose intolerant yet resistant to fasting hyperglycemia and hyperinsulinemia.

Claudia E Robert-Cooperman1, Camella G Wilson, Brant R Burkhardt.   

Abstract

The recent creation of the PANDER (pancreatic-derived factor) knockout (PANKO) and acute mouse models have revealed a biological function in the regulation of glycemic levels via promotion of hepatic glucose production (HGP) and pancreatic β-cell insulin secretion. Therefore, we hypothesized that the absence of PANDER may afford some degree of protection from high-fat diet (HFD) induced fasting hyperglycemia. On HFD, fasting glycemic levels were significantly lower in the PANKO mice. Also, fasting insulin levels and the in vivo insulin response following glucose injection were inhibited in PANKO mice. The lowered fasting glycemic levels are attributed to decreased HGP due to the absence of PANDER. Overall, our findings further indicate PANDER impacts glycemic levels and may represent a potential but complicated therapeutic target.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21486565      PMCID: PMC5754927          DOI: 10.1016/j.febslet.2011.04.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Genetic models of obesity and energy balance in the mouse.

Authors:  S W Robinson; D M Dinulescu; R D Cone
Journal:  Annu Rev Genet       Date:  2000       Impact factor: 16.830

Review 2.  Inflammation and insulin resistance.

Authors:  Steven E Shoelson; Jongsoon Lee; Allison B Goldfine
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 3.  Pathogenesis of type 2 diabetes mellitus.

Authors:  Jack L Leahy
Journal:  Arch Med Res       Date:  2005 May-Jun       Impact factor: 2.235

4.  The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.

Authors:  Rana K Gupta; Marko Z Vatamaniuk; Catherine S Lee; Reed C Flaschen; James T Fulmer; Franz M Matschinsky; Stephen A Duncan; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

5.  Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production.

Authors:  Simon J Fisher; C Ronald Kahn
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

6.  Quantifying gluconeogenesis during fasting.

Authors:  V Chandramouli; K Ekberg; W C Schumann; S C Kalhan; J Wahren; B R Landau
Journal:  Am J Physiol       Date:  1997-12

7.  Gluconeogenesis in non-obese diabetic (NOD) mice: in vivo effects of vandadate treatment on hepatic glucose-6-phoshatase and phosphoenolpyruvate carboxykinase.

Authors:  R Mosseri; T Waner; M Shefi; E Shafrir; J Meyerovitch
Journal:  Metabolism       Date:  2000-03       Impact factor: 8.694

8.  Targeted disruption of pancreatic-derived factor (PANDER, FAM3B) impairs pancreatic beta-cell function.

Authors:  Claudia E Robert-Cooperman; Jason R Carnegie; Camella G Wilson; Jichun Yang; Joshua R Cook; Jianmei Wu; Robert A Young; Bryan A Wolf; Brant R Burkhardt
Journal:  Diabetes       Date:  2010-06-21       Impact factor: 9.461

9.  Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells.

Authors:  Xiaopei Cao; Zhiyong Gao; Claudia E Robert; Scott Greene; Gang Xu; Weizhen Xu; Ewan Bell; Don Campbell; Yuan Zhu; Robert Young; Matteo Trucco; James F Markmann; Ali Naji; Bryan A Wolf
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

10.  High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes.

Authors:  B A Haber; S Chin; E Chuang; W Buikhuisen; A Naji; R Taub
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  7 in total

Review 1.  PANcreatic-DERived factor: novel hormone PANDERing to glucose regulation.

Authors:  Camella G Wilson; Claudia E Robert-Cooperman; Brant R Burkhardt
Journal:  FEBS Lett       Date:  2011-06-12       Impact factor: 4.124

2.  FAM3B mediates high glucose-induced vascular smooth muscle cell proliferation and migration via inhibition of miR-322-5p.

Authors:  Wenxiang Zhang; Siyu Chen; Zhao Zhang; Chen Wang; Chang Liu
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

3.  Circulating PANDER concentration is associated with increased HbA1c and fasting blood glucose in Type 2 diabetic subjects.

Authors:  Catherine B MarElia; Melanie N Kuehl; Tiffany A Shemwell; Amy C Alman; Brant R Burkhardt
Journal:  J Clin Transl Endocrinol       Date:  2018-02-23

4.  Enhanced glucose tolerance in pancreatic-derived factor (PANDER) knockout C57BL/6 mice.

Authors:  Shari L Moak; Grace C Dougan; Catherine B MarElia; Whitney A Danse; Amanda M Fernandez; Melanie N Kuehl; Mark G Athanason; Brant R Burkhardt
Journal:  Dis Model Mech       Date:  2014-09-12       Impact factor: 5.758

5.  Altered Body Weight Regulation in CK1ε Null and tau Mutant Mice on Regular Chow and High Fat Diets.

Authors:  Lili Zhou; Keith C Summa; Christopher Olker; Martha H Vitaterna; Fred W Turek
Journal:  Genet Res Int       Date:  2016-04-06

6.  Elevated circulating level of a cytokine, pancreatic-derived factor, is associated with metabolic syndrome components in a Chinese population.

Authors:  Xiaopei Cao; Chijiao Yang; Fenghua Lai; Zhenzhen Hong; Huimei Lin; Juan Liu; Yanbing Li
Journal:  J Diabetes Investig       Date:  2015-11-14       Impact factor: 4.232

7.  FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes.

Authors:  Yujing Chi; Yuhong Meng; Junpei Wang; Weili Yang; Zhe Wu; Mei Li; Di Wang; Fangfang Gao; Bin Geng; Lu Tie; Weiping Zhang; Jichun Yang
Journal:  J Cell Mol Med       Date:  2018-11-28       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.